Christopher Lieu, University of Colorado Cancer Center (IMAGE)
Caption
Christoper Lieu, M.D., and colleagues show increased survival with addition of vemurafenib to common therapy for metastatic colorectal cancer.
Credit
University of Colorado Cancer Center
Usage Restrictions
With attribution
License
Licensed content